Chronic disease management in the post COVID era - the value of point of care testing for cardiovascular risk and kidney disease management in diabete...
Diabetes Care, 2020 The American Diabetes Association (ADA) Standards of Medical Care in Diabetes outlines current clinical practice recommendations for diabetes care, including treatment goals, tools to evaluate quality of care and recommendations for lipid profile monitoring (which can be conducted via POC testing). The guidelines recommend obtaining a lipid profile at the time of diabetes diagnosis, at an initial medical evaluation, and every ...
Cardiovascular disease and risk management: standards of care in diabetes – 2020
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.
Point-of-care testing to improve cost-effectiveness of health check programmes in primary care
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
Point-of-care testing for reducing risk and improving management of infectious diseases
Health Information and Quality Authority (HIQA), published online April 2019This health technology assessment (HTA) aimed to establish the clinical and cost-effectiveness of CRP POCT, plus examined the organisational implications of the potential introduction of the technology into primary care. A summary of key findings is provided below:
Health Technology Assessment of CRP POCT to guide antibiotic prescribing for acute respiratory tract infections in primary care settings
Jan Verbakel, Joseph Lee, Clare Goyder, Pui San Tan, Thanusha Ananthakumar, Philip Turner, Gail Hayward, and Ann Van den BruelBMJ Open, 2019The aim of this review was to collate all available evidence on the impact of C-reactive protein (CRP) point-of-care testing (POCT) on patient-relevant outcomes in children and adults in ambulatory care.
Impact of CRP POC testing in ambulatory care: a systematic review and meta-analysis
European Network for Health Technology Assessment (EUnetHTA), published online January 2019This collaborative assessment on C-reactive protein (CRP) point-of-care testing (POCT) aims to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs). The assessment sought to answer three questions by conducting three separate systematic reviews:
C-reactive protein POCT to guide antibiotic prescribing in primary care settings for acute respiratory tract infections
Erna Lenters-Westra, and Emma EnglishJournal of Diabetes Science and Technology 2018;12(4):762-770Given the importance of point-of-care testing (POCT) in healthcare delivery, Lenters-Westra and English investigate the quality criteria used to evaluate POCT devices to establish whether these perform to the same standard as main laboratory analysers. They apply the Clinical and Laboratory Standards Institute (CLSI) protocols EP-5 and EP-9 to evalua...
Evaluation of four HbA1c POC devices using international quality targets: are they fit for the purpose?
Emma English, Larissa-Nele Schaffert and Erna Lenters-WestraClinical Laboratory International, November 2018In this article, the authors discuss the benefits of point-of-care testing (POCT), from expediting diagnosis, to ease of monitoring, to cost and time efficiencies in rural and hard-to-reach environments. They go on to explain the different analytical methods for HbA1c measurement, the quality criteria for HbA1c POCT and the quality of POC d...
Point-of-care testing for HbA1c: clinical need and analytical quality
Erna Lenters-Westra and Emma EnglishJournal of Diabetes Science and Technology 2019;13(6):1154-1157Lenters-Westra and English consider the pros and cons of different methods for evaluating the performance of HbA1c point-of-care testing (POCT) devices, including:
Investigating the quality of POCT devices for HbA1c: what are our next steps?
Vincent Delatour, Noémie Clouet-Foraisona, Stéphane Jaisson, Patricia Kaiser and Philippe GilleryClinical Chemistry and Laboratory Medicine 2019;25(57)10:1623-1631In this article Delatour and co-authors explore the trueness of external quality assessment (EQA) programmes for determining accuracy of HbA1c testing in diabetes (both lab-based and point-of-care systems). Commutability of processed EQA materials was found to be highly heterogeneous an...
Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job?
The ERS international congress on 7–9 September 2020 delivered the latest innovations in respiratory medicine, plus offered an opportunity to interact and connect with the respiratory community virtually.
European Respiratory Society virtual international congress 2020
An international expert panel discusses POCT related to COVID-19 severity assessment and risk prediction, plus covers the role of POCT in antimicrobial resistance during the pandemic, in this video seminar originally delivered live on 9 September 2020. Hear from Professor Nicholas Francis (UK), Professor Ivan Gentile (Italy), Dr Carl Llor (Spain), Professor Dag Berild (Norway) and Dr Aggy York (UK) by clicking here.
Hear expert opinion on the use of CRP point-of-care testing for COVID-19 management and reduction of antimicrobial resistance
Check out the on-demand educational recording from Africa Online Healthcare Week 2020 by clicking here. Dr Susanne Emmerich (Germany) discusses the relationship between diabetes and COVID-19, and how HbA1c point-of-care testing (POCT) impacts glycemic control in diabetic patients. Dr Carl Llor (Spain) discusses the value of C-reactive protein (CRP) POCT to aid assessment of COVID-19 and prevent unnecessary prescription of antibiotics.
View expert presentations on point-of-care testing for diabetes and in the context of COVID-19
en
pt
立即访问
認證內容
没有更多结果
By using this site, you agree with our use of cookies.
